Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0RF4J
|
|||
| Drug Name |
CLL1 CAR-T Cell
|
|||
| Drug Type |
CAR T Cell Therapy (Dual specific)
|
|||
| Indication | Acute myeloid leukaemia [ICD-11: 2A60] | Phase 2/3 | [1] | |
| Company |
Fujian Medical University
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Myeloid inhibitory C-type lectin-like receptor (CD371) | Target Info | CAR-T-Cell-Therapy(Dual specific) | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03631576) CD123/CLL1 CAR-T Cells for R/R AML | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.